Morrisville, NC, United States of America

Cunyu Zhang


Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Cunyu Zhang

Introduction

Cunyu Zhang is a prominent inventor based in Morrisville, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target CRF receptors. With a total of 3 patents, his work has the potential to impact the treatment of various central nervous system disorders.

Latest Patents

Cunyu Zhang's latest patents include innovative compounds such as substituted arylpyrazines. These arylpyrazine compounds are designed to bind with high affinity and selectivity to CRF receptors, including human CRF receptors. The invention encompasses methods for treating disorders associated with CRF receptors, particularly CNS-related disorders like affective disorders and both acute and chronic neurological diseases. Another notable patent involves novel 5-substituted-2-arylpyrazine compounds, which act as selective modulators of CRF receptors. These compounds are useful in treating stress, anxiety, depression, cardiovascular disorders, and eating disorders. Additionally, they serve as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding.

Career Highlights

Cunyu Zhang is currently associated with Neurogen Corporation, where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative solutions for complex medical challenges.

Collaborations

Cunyu collaborates with talented professionals in his field, including Taeyoung Yoon and Ping Ge. Their combined expertise enhances the research and development initiatives at Neurogen Corporation.

Conclusion

Cunyu Zhang's contributions to the field of pharmaceutical sciences through his innovative patents demonstrate his commitment to improving treatment options for CNS disorders. His work continues to pave the way for advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…